EVOTAZ

Medicinal product

(Invented) name

EVOTAZ

Active substance (s)

Atazanaviras/Kobicistatas

Strength

300 mg/150 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J05AR15, Atazanavir and cobicistat

Marketing authorisation holder

Bristol-Myers Squibb Pharma EEIG, Airija

Date of authorisation

2015-07-13

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10b

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Atazanaviras	300 mg
Kobicistatas	150 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
63173	77588	1077588	buteliukas	N30		Receptinis	EU/1/15/1025/001	Netiekiama	-	-	No	-	-
63174	77589	1077589	buteliukas	N90 (3x30)		Receptinis	EU/1/15/1025/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2015-07-13	Registruotas